Sanofi is in the final stages of selling its European generics business, Zentiva, to private equity firm Advent International. The companies have signed a share purchase agreement valued at €1.9 ...
It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...
IBM Watson is a pretty big name in the AI world, and for good reason. It’s not just one tool, but more like a whole suite of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback